| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sandra Torres Galván, María Flores-López, Pablo Romero-Sanchiz, Nerea Requena-Ocaña, Oscar Porras-Perales, Raquel Nogueira-Arjona, Fermín Mayoral, Pedro Araos, Antonia Serrano, Roberto Muga, Francisco Javier Pavón, Nuria García-Marchena, Fernando Rodríguez de Fonsec. Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder. Scientific reports. vol 11. issue 1. 2021-11-04. PMID:34211033. |
in particular, we investigated the association between g-csf concentrations and comorbid major depressive disorder (mdd) in patients with cocaine and alcohol use disorders (cud and aud, respectively). |
2021-11-04 |
2023-08-13 |
human |
| Tmader Alballa, Edward L Boone, Liangsuo Ma, Andrew Snyder, F Gerard Moelle. Exploring the relationship between white matter integrity, cocaine use and GAD polymorphisms using Bayesian Model Averaging. PloS one. vol 16. issue 7. 2021-11-03. PMID:34310624. |
past investigations utilizing diffusion tensor imaging (dti) have demonstrated that cocaine use disorder (cud) yields white matter changes, primarily in the corpus callosum. |
2021-11-03 |
2023-08-13 |
Not clear |
| Youwei Zhu, Yan Zhao, Xiaomin Xu, Hang Su, Xiaotong Li, Na Zhong, Haifeng Jiang, Jiang Du, Min Zha. Aberrant expression of General psychiatry. vol 34. issue 5. 2021-11-02. PMID:34723091. |
aberrant expression of cocaine use disorder (cud) and associated psychosis are major public health issues worldwide, along with high relapse outcome and limited treatment options. |
2021-11-02 |
2023-08-13 |
Not clear |
| Nerea Requena-Ocaña, María Flores-Lopez, Alicia San Martín, Nuria García-Marchena, María Pedraz, Juan Jesús Ruiz, Antonia Serrano, Juan Suarez, Francisco Javier Pavón, Fernando Rodríguez de Fonseca, Pedro Arao. Influence of gender and education on cocaine users in an outpatient cohort in Spain. Scientific reports. vol 11. issue 1. 2021-10-26. PMID:34686732. |
the aim was to estimate gender-based differences and the influence of educational level on the clinical variables associated with cocaine use disorder (cud). |
2021-10-26 |
2023-08-13 |
Not clear |
| Maria Alías-Ferri, Nuria García-Marchena, Joan Ignasi Mestre-Pintó, Pedro Araos, Esperanza Vergara-Moragues, Francina Fonseca, Francisco González-Saiz, Fernando Rodríguez de Fonseca, Marta Torrens, Neurodep Grou. Cocaine and depressive disorders: When standard clinical diagnosis is insufficient. Adicciones. vol 33. issue 3. 2021-10-25. PMID:32100040. |
cocaine use is a growing global health problem and patients with cocaine use disorders (cud) present several complications, including high rates of major depression. |
2021-10-25 |
2023-08-13 |
human |
| Kimberly Ann Yonkers, Ariadna Forray, Charla Nich, Kathleen M Carroll, Cristine Hine, Brian C Merry, Howard Shaw, Julia Shaw, Mehmet Sofuogl. Progesterone Reduces Cocaine Use in Postpartum Women with a Cocaine Use Disorder: A Randomized,Double-Blind Study. The lancet. Psychiatry. vol 1. issue 5. 2021-10-21. PMID:25328863. |
we sought to test whether progesterone replacement reduces cocaine use in postpartum women with a cocaine use disorder (cud). |
2021-10-21 |
2023-08-13 |
Not clear |
| Natalie Lowry, John Marsden, Bethany Clydesdale, Brian Eastwood, Eva Maria Havelka, Camille Goet. Acute impact of self-guided mental imagery on craving in cocaine use disorder: a mixed-methods analysis of a randomized controlled trial. Addiction (Abingdon, England). vol 116. issue 9. 2021-09-30. PMID:33405313. |
mental imagery manipulations are used to treat several psychological disorders, but their utility in treating cocaine use disorder (cud) is unknown. |
2021-09-30 |
2023-08-13 |
Not clear |
| Violaine Mongeau-Pérusse, Suzanne Brissette, Julie Bruneau, Patricia Conrod, Simon Dubreucq, Guillaume Gazil, Emmanuel Stip, Didier Jutras-Aswa. Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo-controlled trial. Addiction (Abingdon, England). vol 116. issue 9. 2021-09-30. PMID:33464660. |
cocaine use disorder (cud) is a significant public health concern for which no efficacious pharmacological interventions are available. |
2021-09-30 |
2023-08-13 |
Not clear |
| Laura Brandt, Thomas Chao, Sandra D Comer, Frances R Levi. Pharmacotherapeutic strategies for treating cocaine use disorder-what do we have to offer? Addiction (Abingdon, England). vol 116. issue 4. 2021-09-29. PMID:32888245. |
however, despite substantial research efforts, no pharmacotherapies are approved for the treatment of cocaine use disorder (cud). |
2021-09-29 |
2023-08-13 |
Not clear |
| Janna Cousijn, K Richard Ridderinkhof, Anne Marije Kaa. Sex-dependent prefrontal cortex activation in regular cocaine users: A working memory functional magnetic resonance imaging study. Addiction biology. vol 26. issue 5. 2021-09-29. PMID:33508891. |
although two thirds of patients with a cocaine use disorder (cud) are female, little is known about sex differences in the (neuro)pathology of cud. |
2021-09-29 |
2023-08-13 |
Not clear |
| Janna Cousijn, K Richard Ridderinkhof, Anne Marije Kaa. Sex-dependent prefrontal cortex activation in regular cocaine users: A working memory functional magnetic resonance imaging study. Addiction biology. vol 26. issue 5. 2021-09-29. PMID:33508891. |
the aim of this explorative study was to investigate sex-dependent differences in prefrontal cortex (pfc) functioning during a working memory (wm) functional magnetic resonance imaging (fmri) task in regular cocaine users (cus), as pfc deficits are implicated in the shift from recreational cocaine use to cud. |
2021-09-29 |
2023-08-13 |
Not clear |
| Jin H Yoon, Robert Suchting, Constanza de Dios, Jessica N Vincent, Sarah A McKay, Scott D Lane, Joy M Schmit. Decreased cocaine demand following contingency management treatment. Drug and alcohol dependence. vol 226. 2021-09-28. PMID:34198136. |
a hypothetical cocaine purchasing task (cocpt) was used to assess changes in cocaine demand in the context of contingency management (cm) treatment for cocaine use disorder (cud). |
2021-09-28 |
2023-08-13 |
human |
| Derek Blevins, Kenneth M Carpenter, Diana Martinez, John J Mariani, Frances R Levi. An adaptive clinical trial design for cocaine use disorder: Extended-release amphetamine salts for early behavioral intervention non-responders. Contemporary clinical trials. vol 98. 2021-09-24. PMID:33086160. |
cocaine use disorder (cud) persists as a major public health problem in the united states. |
2021-09-24 |
2023-08-13 |
Not clear |
| David S Jacobs, Bruce E Blough, Stephen J Kohu. Reinforcing and Stimulant-Like Effects of Methamphetamine Isomers in Rhesus Macaques. The Journal of pharmacology and experimental therapeutics. vol 378. issue 2. 2021-09-23. PMID:33986037. |
monoamine releasers such as d-methamphetamine (d-ma) can reduce cocaine use in laboratory studies and have been forwarded for the management of cocaine use disorder (cud). |
2021-09-23 |
2023-08-13 |
Not clear |
| Mieke H J Schulte, Anna E Goudriaan, Wouter J Boendermaker, Wim van den Brink, Reinout W Wier. The effect of N-acetylcysteine and working memory training on glutamate concentrations in the dACC and rACC in regular cocaine users - A randomized proof of concept study. Neuroscience letters. vol 762. 2021-09-14. PMID:34332028. |
current treatments for cocaine use disorder (cud) are not very effective and better treatments are needed. |
2021-09-14 |
2023-08-13 |
Not clear |
| Morgan H James, Jennifer E Fragale, Shayna L O'Connor, Benjamin A Zimmer, Gary Aston-Jone. The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse. Neuropharmacology. vol 183. 2021-09-13. PMID:33091458. |
an estimated 50-90% of individuals with cocaine use disorder (cud) also report using alcohol. |
2021-09-13 |
2023-08-13 |
rat |
| Morgan H James, Jennifer E Fragale, Shayna L O'Connor, Benjamin A Zimmer, Gary Aston-Jone. The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse. Neuropharmacology. vol 183. 2021-09-13. PMID:33091458. |
thus, pharmaceutical strategies to treat cud would ideally reduce the motivational properties of cocaine, alcohol, and their combination, as well as reduce the onset of anxiety during drug withdrawal. |
2021-09-13 |
2023-08-13 |
rat |
| Heather E Webber, Constanza de Dios, Margaret C Wardle, Robert Suchting, Charles E Green, Joy M Schmitz, Scott D Lane, Francesco Versac. Electrophysiological responses to emotional and cocaine cues reveal individual neuroaffective profiles in cocaine users. Experimental and clinical psychopharmacology. 2021-09-03. PMID:33630644. |
we tested whether individuals with cocaine use disorder (cud) show similar neuroaffective profiles to smokers. |
2021-09-03 |
2023-08-13 |
human |
| Noèlia Fernàndez-Castillo, Judit Cabana-Domínguez, Roser Corominas, Bru Corman. Molecular genetics of cocaine use disorders in humans. Molecular psychiatry. 2021-08-28. PMID:34453125. |
cocaine use disorders (cud) are complex multifactorial conditions driven by both genetic and environmental influences. |
2021-08-28 |
2023-08-13 |
Not clear |
| Noèlia Fernàndez-Castillo, Judit Cabana-Domínguez, Roser Corominas, Bru Corman. Molecular genetics of cocaine use disorders in humans. Molecular psychiatry. 2021-08-28. PMID:34453125. |
importantly, not all people who use cocaine develop cud, and this is due, at least in part, to biological factors that are encoded in the genome of individuals. |
2021-08-28 |
2023-08-13 |
Not clear |